• 1 January 1984
    • journal article
    • research article
    • Vol. 29  (4) , 198-208
Abstract
Oral contraceptive (OC) usage and cardiovascular mortality rates for all women (and men) of reproductive age, but specifically of those aged 35-44 yr, were examined in the UK. OC-usage increased from 14.1 million packs in 1968, to 45.1 million in 1976, decreasing to 37.1 million in 1980. Ischemic heart disease (IHD) mortality rates for 1968-1980 for women of reproductive age of 15-34 yr were stable: for those aged 35-44 yr the rates fell gradually by 19%. Mortality rates for all types of cerebrovascular disease (CVD) for 1969-1978 remained stable for women of 15-34 yr but for women of 35-44 yr rates for subarachnoid hemorrhage and cerebral hemorrhage (the 2 largest groups) declined by 11% and 34%, respectively. The absence of a positive correlation between OC usage and cardiovascular mortality rates is difficult to explain if OC are the cause of fatalities, as claimed by some epidemiological studies. Possible counteracting variables.sbd.such as decreased ascertainment or decreased usage by women of 35-44 yr, or decreased relative risk over the time period, which might account for this paradoxical result, were examined but discarded as being unlikely. Evidence from other data, e.g., the similarity of male and female mortality rates for each group, the increased mortality rates of women of 45-54 yr (who do not take OC), and the similarity of mortality rates in women in years when OC-usage was widely different.sbd.all suggest that a counteracting variable does not exist. The data on cardiovascular mortality rates in the UK, showing an absence of positive correlation with OC-usage, are thus opposed to the conclusions of epidemiological studies claiming an increased risk of cardiovascular mortality due to OC and specifically contradict the claim that such increased risk is found in 35-44 yr-old OC-users.